An effective 5-fluorouracil, levofolinate, and oxaliplatin therapy for recurrent breast cancer: a case report

Table 1 Operative history of our case

No. of surgery	Age (years)	Location	Procedure	Stage	Immunohistochemical staining of surgical specimen					Adjuvant therapy
No. of surgery	Age (years)	Location	Procedure	Stage	ER	PR	HER2	CK7	CK20	Adjuvant therapy
1	29	Lt-breast	Bq+Ax	IIA	(+)	(+)	(+)	(+)	(-)	Rad, UFT+TAM
2	39	Rt-breast	Bq+Ax	IIA	(-)	(-)	(+++)	(+)	(±)	Rad, CEF, PTX+Tmab
3	43	Lt-breast	Bt+Ax	IIA	(-)	(-)	(-)	(+)	(-)
4	43	T/C	LAC	IIIC	(-)	(-)	(-)	(+)	(+)	FOLFOX

Ax: Axillary lymphadenectomy, Bq: Quadrantectomy, Bt: Mastectomy, CEF: Cyclophosphamide + epirubicin + 5-fluorouracil, CK: Cytokeratin, ER: Estrogen receptor, FOLFOX: 5-fluorouracil, levofolinate, and oxaliplatin, HER2: Human epidermal growth factor receptor 2, LAC: Laparoscopic-assisted colectomy, Lt: Left, PR: Progesterone receptor, PTX: Paclitaxel, Rad: Postoperative radiation therapy, Rt: Right, Stage: TNM Classification Union for International Cancer Control 7th edition, TAM: Tamoxifen, T/C: Transverse colon, Tmab: Trastuzumab, UFT: Uracil-tegafur. Operative history showing the operative procedure, Stage, the outcome of immunohistochemical staining, and postoperative therapies.

ISSN: 1752-1947